Patient Pathfinder: Clinical Trials
Clinical Trials for Lung Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 986 active Lung Cancer trials
Study to Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC)
Study Type: Interventional Phase 1
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
Study Type: Interventional
Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer
Study Type: Interventional
MK-2870 Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
Study Type: Interventional Phase 3
Lung Cancer Screening Eligibility Assessment
Study Type: Interventional
Increasing Adherence to Lung Cancer Screening
Study Type: Interventional
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Study Type: Interventional Phase 1
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Study Type: Observational
There are 986 active Lung Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now